Assessment of cardiovascular risk in patients with gout and nonalcoholic fatty liver disease

被引:0
作者
Smiyan, S. I. [1 ]
Danchak, S. V. [1 ]
机构
[1] Ternopil State Med Univ, Dept Internal Med 2, Ternopol, Ukraine
来源
PATHOLOGIA | 2015年 / 03期
关键词
Gout; Liver Diseases; Cardiovascular Diseases;
D O I
10.14739/2310-1237.2015.3.55609
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aim. Cardiovascular diseases are observed more frequently in patients with gout as compared to other rheumatologic pathologies. Methods and results. 120 patients with gout were examined to study the frequency of cardiovascular risk in patients combined with nonalcoholic fatty liver disease (NAFLD). To determine cardiovascular risk SCORE chart was used, the diagnosis of nonalcoholic fatty liver disease was confirmed by share wave elastography. Conclusion. In patients with gout and nonalcoholic fatty liver disease there is increasing of cardiovascular risk level, low cardiovascular risk is found in 16.2%, moderate in 25.0%, high in 19.1% and very high risk in 39.7% of cases. Among patients without associated liver injury another tendency is observed, particularly low risk was found in 32.7%, moderate in 40.4%, high in 17.3% and very high risk in 9.6% of cases. Risk factors for cardiovascular disease in patients with gout combined with nonalcoholic fatty liver disease include hypertension, hypercholesterolemia, hyperuricemia, smoking, an increase of patients' age, body mass index. The level of hyperuricemia was significantly (p<0.01) higher among patients with nonalcoholic fatty liver disease patients and increased together with increasing risk of cardiovascular catastrophes.
引用
收藏
页码:36 / 40
页数:5
相关论文
共 50 条
  • [31] Gout, hyperuricemia, and the risk of cardiovascular disease: Cause and effect?
    Shah A.
    Keenan R.T.
    Current Rheumatology Reports, 2010, 12 (2) : 118 - 124
  • [32] Dietary patterns in relation to hepatic fibrosis among patients with nonalcoholic fatty liver disease
    Soleimani, Davood
    Ranjbar, Golnaz
    Rezvani, Reza
    Goshayeshi, Ladan
    Razmpour, Farkhonde
    Nematy, Mohsen
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 315 - 324
  • [33] Association between nonalcoholic fatty liver disease and coronary artery disease
    Vilar, Consuelo P.
    Cotrim, Helma P.
    Florentino, Gesira S.
    Barreto, Cibelle P. V.
    Florentino, Andre Vinicius A.
    Bragagnoli, Gerson
    Schwingel, Paulo A.
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2013, 59 (03): : 290 - 297
  • [34] Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care
    Yoneda, Masato
    Kobayashi, Takashi
    Iwaki, Michihiro
    Nogami, Asako
    Saito, Satoru
    Nakajima, Atsushi
    GUT AND LIVER, 2023, 17 (06) : 843 - 852
  • [35] Pilot study: asymptomatic hyperuricemia patients with obesity and nonalcoholic fatty liver disease have increased risk of double contour sign
    Min, Hong Ki
    Cho, Hyonjoung
    Park, Sung-Hwan
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (06) : 1517 - 1523
  • [36] New pharmacological treatment options for nonalcoholic fatty liver disease
    Stefan, Norbert
    INTERNIST, 2020, 61 (07): : 759 - 765
  • [37] Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
    Kim, Kyung-Soo
    Lee, Byung-Wan
    Kim, Yong Jin
    Lee, Dae Ho
    Cha, Bong-Soo
    Park, Cheol-Young
    DIABETES & METABOLISM JOURNAL, 2019, 43 (02) : 127 - 143
  • [38] Hypoadiponectinemia and insulin resistance are associated with nonalcoholic fatty liver disease
    Yoon, D
    Lee, SH
    Park, HS
    Lee, JH
    Park, JS
    Cho, KH
    Kim, SM
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2005, 20 (03) : 421 - 426
  • [39] The mediterranean diet, hepatic steatosis and nonalcoholic fatty liver disease
    Velasco, Nicolas
    Contreras, Alvaro
    Grassi, Bruno
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2014, 17 (05) : 453 - 457
  • [40] Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
    Wijarnpreecha, Karn
    Aby, Elizabeth S.
    Ahmed, Aijaz
    Kim, Donghee
    CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (02) : 221 - 235